Alcohol, Internet usage in
Drug Delivery System Development of Meloxicam Coated Ibuprofen Microparticles
Dr. C. Kumaresan
Pharmaceutical Formulator,
Chennai, Tamil nadu, India.
*Corresponding Author E-mail: kumaresan06051979@gmail.com
ABSTRACT:
Peoples stay alone sometimes
due to lack of freedom from surrounding, they choose to escape from surrounding
thereby people drinks alcohol and uses internet tools such as laptop, mobile
phone and computer. It is called abuse of alcohol and internet facility. The
management of alcohol drinks and internet tool usage in public to be in
control. In Pharmaceuticals, Alcohols used as solvent for solid dosage forms
such as tablet granulation, tablet coating solution, microparticle drug layer
coating, semisolid dosage forms such as paste, jells, creams and liquid dosage
forms such as suspension because of easy evaporation characteristics. In
Pharmaceuticals, Internet used for email purposes, online operated and computer
managed compression machine, tablet counting machine, capsule and liquid
filling machine. This research paper observed for drug meloxicam layering by
film coating on tablet ibuprofen.
KEYWORDS: Meloxicam,
Ibuprofen, Microparticles
INTRODUCTION:
Generally peoples drinks
alcohol for unconscious treatment of their anxiety. Per year 88,000 peoples
death by alcohol intake due to health disorder such as pancreatitis, cirrhosis,
withdrawl symptoms and other health problems such as head and neck cancer and
heart diseases because of heavy drinking1. Drinking alcohol with
womans are main problem, which mean alcohol abuse. There are many health
warnings and greater social awareness. Eventhough alcohol disorder doubled for
woman since 2002. Alcoholism is the term represents alcohol use disorder.
Alcoholism represent problems of alcohol withdrawl symptoms, difficulty in
emotional management.
The increase level of use of
alcohol give more than 200 diseases including cancer and psychiatric disorder2.
Woman affected 5 times more health disorder than man by alcohol misuses.
alcohol/sprits bevarages or liquor contain alcohol content given in Table 1.
The alcohol content in liquor
products. Table I.
|
Liquor Products |
Alcohol content |
|
Beer |
4-8 % |
|
Brandy |
35-60% |
|
Whisky |
40-50% |
|
Vodka |
40-95% |
|
Scotch whisky |
35-50% |
|
Wine |
40-50% |
|
Gin |
36-50% |
|
Rum |
40-50% |
Usually internet abuse causes
health and psychiatric disorder such as writing complains and writing
information to wrong peoples. The Peoples should not email from personal email
to official peoples emails and should not write personal matter from official
email to official peoples. The official documents should not email from
personal email or official email or pen drive from laptop, mobile and computers
are avoided. In the same way official document transaction should be monitored
online with the online approval of documents. The abuse of alcohol and internet
caused by self and others should be controlled as per prevention is better than
cure3. The abuse alcohol and internet users should be
monitored by authority.
MATERIALS AND METHODS:
The ibuprofen obtained from
madras pharmaceuticals, chennai and meloxicam dichloromethane, ethanol,
mannitol, hydroxy propyl methyl cellulose obtained obtained from orchid
laboratories, Chennai. The other chemical obtained from sigma laboratories,
chennai.
Preparation of ibuprofen
microparticles:
The modified solvent evaporation
method used to prepare ibuprofen microparticles. The solvent evaporation is the
method of frequently used method of microparticle preparation. The ibuprofen
aqueous solution contains viscosity enhancer and stablising agent added to
solvents, dichloromethane: acetone in 1:1 ratio contain polymer. The water oil
emulsion cleared by continuous stirring for 24 hours. The ibuprofen
microparticles collected by centrifugation4. The prepared
microparticles characterized.
Particle size and shape of
microparticles:
The particle size analysed by
laser diffraction method. The microparticles particles size 10µ ± 3 µ. The particle shape obtained from scanning
electron microscope, microparticles are spherical in nature.
The drug layering:
The 5g of prepared
microparticle coated with 100 mg of meloxicam. The meloxicam and coating
material dispersed in organic solvent dichloromethane and acetone. The prepared
microparticles kept in coating pan and 2 mg of meloxicam solution sprayed over
100mg microparticles. The dummy is used and optimized drug layering of
100mg:2mg of ibuprofen: meloxicam respectively.
In vitro diffusion study:
The in vitro diffusion
study carried out for meloxicam coated drug layer on ibuprofen microparticles.
100 ml of buffer solution is used, the 1ml of solution is withdrawn from 1, 4,
8, 12 and 24 hours to evaluate the drug percentage release. The Ultra-Violet
visible spectrophotometer used to find the drug content. About 79-80% drug
release and 82-91% drug release found in ibuprofen and meloxicam respectively.
The final microparticles size 12µ ± 4 µ. and spherical shape were evaluated
with laser diffraction method and scanning electron microscope respectively.
CONCLUSION:
The prepared drug coated
microparticles provide the satisfactory result. The further broad review of the
research provides the best clinical effect.
ACKNOWLEDGEMENT:
I am gratifying thanks to my
teachers, classmates, collegues and friends. I am thankful to Dr. K. Sathish
Kumar, Dr. GnanaPrakash, Dr. R. Parthiban, Department of chemical engineering,
Dr.S. Salivahanan, SSN college of engineering, Kalavakkam, Chennai, Tamilnadu,
India. I am grateful for help and support of Mr.D. Ragupratap Department of
Pharmacy, Annamalai University, Chidambaram.
REFERENCES:
1.
www.prevention.com,
our drinking problem, 01/05/2018, p.no 77-85.
2.
https://www.alcoholwebindia.in/content/types-alcoholic-beverages,
10/5/2019, 1.46 PM
3.
https://www.alcohol.org/statistics-information/abv/,
11/5/2019, 3.12 PM
4.
https://www.frontiersin.org/articles/10.3389/fphys.2017.01120/full,
12/5/2019, 1.08 PM
Received on 06.12.2019
Modified on 18.01.2020
Accepted on 10.02.2020 ©Asian Pharma Press All
Right
Reserved
Asian J. Pharm.
Tech. 2020; 10(1):27-28.
DOI: 10.5958/2231-5713.2020.00006.9